Logo image of SGN

SIGNING DAY SPORTS INC (SGN) Stock Fundamental Analysis

NYSEARCA:SGN - NYSE Arca - US82670R3057 - Common Stock - Currency: USD

0.6081  -0.03 (-4.98%)

Premarket: 0.6 -0.01 (-1.33%)

Fundamental Rating

1

Taking everything into account, SGN scores 1 out of 10 in our fundamental rating. SGN was compared to 283 industry peers in the Software industry. SGN has a bad profitability rating. Also its financial health evaluation is rather negative. SGN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

SGN had negative earnings in the past year.
SGN had a negative operating cash flow in the past year.
SGN had negative earnings in each of the past 5 years.
SGN had a negative operating cash flow in each of the past 5 years.
SGN Yearly Net Income VS EBIT VS OCF VS FCFSGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

The Return On Assets of SGN (-782.81%) is worse than 97.17% of its industry peers.
Industry RankSector Rank
ROA -782.81%
ROE N/A
ROIC N/A
ROA(3y)-793.82%
ROA(5y)-518.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SGN Yearly ROA, ROE, ROICSGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

SGN has a Gross Margin (67.38%) which is in line with its industry peers.
The Profit Margin and Operating Margin are not available for SGN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 67.38%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SGN Yearly Profit, Operating, Gross MarginsSGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

0

2. Health

2.1 Basic Checks

SGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SGN has more shares outstanding
Compared to 1 year ago, SGN has a worse debt to assets ratio.
SGN Yearly Shares OutstandingSGN Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M
SGN Yearly Total Debt VS Total AssetsSGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

SGN has an Altman-Z score of -56.89. This is a bad value and indicates that SGN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -56.89, SGN is doing worse than 96.11% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -56.89
ROIC/WACCN/A
WACC10.09%
SGN Yearly LT Debt VS Equity VS FCFSGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M

2.3 Liquidity

A Current Ratio of 0.09 indicates that SGN may have some problems paying its short term obligations.
The Current ratio of SGN (0.09) is worse than 96.47% of its industry peers.
A Quick Ratio of 0.09 indicates that SGN may have some problems paying its short term obligations.
With a Quick ratio value of 0.09, SGN is not doing good in the industry: 96.11% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.09
Quick Ratio 0.09
SGN Yearly Current Assets VS Current LiabilitesSGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1M 2M 3M 4M

More info and screens

3

3. Growth

3.1 Past

SGN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -3983.17%.
Looking at the last year, SGN shows a very strong growth in Revenue. The Revenue has grown by 100.72%.
SGN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.88% yearly.
EPS 1Y (TTM)-3983.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2026.24%
Revenue 1Y (TTM)100.72%
Revenue growth 3Y21.88%
Revenue growth 5YN/A
Sales Q2Q%47.98%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SGN Yearly Revenue VS EstimatesSGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 200K 400K 600K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SGN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SGN Price Earnings VS Forward Price EarningsSGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SGN Per share dataSGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15 -20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SGN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SIGNING DAY SPORTS INC

NYSEARCA:SGN (5/20/2025, 8:04:00 PM)

Premarket: 0.6 -0.01 (-1.33%)

0.6081

-0.03 (-4.98%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners8.03%
Inst Owner Change-65.58%
Ins Owners5.53%
Ins Owner Change-5.09%
Market Cap1.21M
AnalystsN/A
Price TargetN/A
Short Float %2.35%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.97
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-20.92
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.55
FCFYN/A
OCF(TTM)-1.54
OCFYN/A
SpS0.31
BVpS-1.11
TBVpS-1.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -782.81%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 67.38%
FCFM N/A
ROA(3y)-793.82%
ROA(5y)-518.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.8%
Cap/Sales 2.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.09
Quick Ratio 0.09
Altman-Z -56.89
F-Score3
WACC10.09%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)475.05%
Cap/Sales(5y)589.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3983.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2026.24%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)100.72%
Revenue growth 3Y21.88%
Revenue growth 5YN/A
Sales Q2Q%47.98%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-61.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y47.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.76%
OCF growth 3YN/A
OCF growth 5YN/A